NCT06068543 2026-03-06
ReFOCUS2
University of Rochester
Phase 2 Recruiting
Clinical Trials
12 trialsNCT07149506 2025-09-08
OCTOPUS-RD
Universidad de Guanajuato
Phase 3 Enrolling by invitation
NCT06015022 2025-09-05
CATCH-B
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT02891538 2025-09-04
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Active not recruiting
NCT05364008 2025-07-25
FRIEND
Yale University
Phase 3 Recruiting
NCT06661083 2025-03-19
The Effect of Natural Molecules on HPV Infection
AGUNCO Obstetrics and Gynecology Centre
Phase NA Completed
NCT06398405 2024-05-03
A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT06314113 2024-03-15
EGCG-HPV
University of Palermo
Recruiting
NCT04177693 2023-06-05
Pharmacokinetics and Hepatic Safety of EGCG
Yale University
Phase 1 Completed
NCT01317953 2019-04-05
Oral Green Tea Extract for Small Cell Lung Cancer
Shandong Cancer Hospital and Institute
Available
NCT01311869 2013-10-24
Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids
Meharry Medical College
Phase 2 Terminated
NCT00676780 2012-08-08
Green Tea Extract and Prostate Cancer
Louisiana State University Health Sciences Center Shreveport
Phase 2 Completed